Mono-2-ethylhexyl phthalate drives progression of PINK1-parkin-mediated mitophagy via increasing mitochondrial ROS to exacerbate cytotoxicity
2020 · Redox Biology · 100 citations
https://doi.org/10.1016/j.redox.2020.101776
K
Keyi Wang
Fudan University(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
439
Papers
5.8K
Citations
38
h-index
147
i10-index
Keyi Wang is an academic researcher from Fudan University. The author has contributed to research in topics: Glycosylation and Glycoproteins Research & Lung Cancer Research Studies & Cancer Genomics and Diagnostics. The author has an h-index of 38, co-authored 374 publications.
ORCID: 0000-0002-6520-1562Papers by this author
worksNR1B2 suppress kidney renal clear cell carcinoma (KIRC) progression by regulation of LATS 1/2-YAP signaling
2019 · Journal of Experimental & Clinical Cancer Research · 61 citations
https://doi.org/10.1186/s13046-019-1344-3
Deciphering extrachromosomal circular DNA in Arabidopsis
2021 · Computational and Structural Biotechnology Journal · 49 citations
https://doi.org/10.1016/j.csbj.2021.01.043
piRNA-1742 promotes renal cell carcinoma malignancy by regulating USP8 stability through binding to hnRNPU and thereby inhibiting MUC12 ubiquitination
2023 · Experimental & Molecular Medicine · 36 citations
https://doi.org/10.1038/s12276-023-01010-3
MUC1-C intersects chronic inflammation with epigenetic reprogramming by regulating the set1a compass complex in cancer progression
2023 · Communications Biology · 23 citations
https://doi.org/10.1038/s42003-023-05395-9
Serum Hypoxia-Inducible Factor 1alpha Levels Correlate with Outcomes After Intracerebral Hemorrhage
2021 · Therapeutics and Clinical Risk Management · 20 citations
https://doi.org/10.2147/tcrm.s313433
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat